Circular RNA platforms Market Forecast 2035 | Key Driver, Restraint, and Growth Opportunity

Analyzing revenue-driving patterns on, "Circular RNA platforms Market Size, Share & Trends Analysis Report by Type (Exonic CircRNAs, Intronic CircRNAs, Exon-Intron CircRNAs (EIciRNAs), Intergenic CircRNAs, Mitochondrial CircRNAs), Technology Platform, Function/Mechanism, Workflow Stage, Sample Type, Service Type, Disease Area/Application Focus, End-User Type, Delivery Model, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2025-2035" A comprehensive report on the circular RNA platforms market highlights key growth drivers, showing how scalable product line expansions, entry into new markets, and strategic partnerships are set to boost revenue, accelerate market adoption, and increase overall market share.

Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the Circular RNA (CircRNA) Platforms Market Research Report: https://marketgenics.co/press-releases/circular-rna-circrna-platforms-market-19161

Global Circular RNA platforms Market Forecast 2035:

The global circular RNA (circRNA) platforms market is projected to expand from approximately USD 213 million in 2025 to around USD 999 million by 2035, registering a robust CAGR of 16.7% over the forecast period. The growth of the global Circular RNA platforms market is mainly fueled by the increased use of circRNA technologies in drug discovery, gene therapy, vaccines, and protein replacement therapies. The increasing investment in biomedical studies, especially in cancer, neurological disease and rare inherited diseases, is rapidly driving the uptake of circRNA platforms, which offer important insights into the molecular processes and treatment of targets. Through technological improvements, such as enhanced circularization processes, efficient delivery solutions, and scalable manufacturing operations, costs of production are reduced, which enhances the accessibility of smaller biotech firms and research centers. Moreover, the market is driven by the increasing use of circRNA platforms in quality control, process optimization, and clinical research. Government and international fund programs, along with specialized RNA research centers globally support long term expansion.

"Key Driver, Restraint, and Growth Opportunity Shaping the Global Circular RNA platforms Market

Rising venture funding, government support, and strategic alliances among biotech and pharmaceutical companies are accelerating the growth in circular RNA (circRNA) platforms market. For instance, CEPI funded USD 3.8 million to Houston Methodist to develop circRNA vaccines against Chikungunya, illustrates growing investment in next-generation RNA technologies. .

The circRNA platforms market is subjected to regulatory barriers that limit the development. Regulatory bodies like the FDA, EMA and other local regulators are still working on a framework of novel RNA modalities of novel circRNA. The lack of properly developed approval routes brings uncertainty in the timing of clinical trials and market access that may slow down the product development timelines and lower investor confidence.

The demand for specialized circRNA manufacturing and QC (Quality Control) services including circularization reactors, impurity profiling and standard release testing represents a significant commercial opportunity, fueling the growth of circular RNA platforms market. For instance, uBriGene offers GMP-grade circRNA manufacturing, encompassing circularization and lipid nanoparticle (LNP) formulation, to stramline the development of RNA therapeutics and vaccines. The scalable and quality platform accelerates production timelines, increase reliability, and supports the efficient commercialization of circRNA based products.

To know more about the Circular RNA (CircRNA) Platforms Market - Download our Sample Report: https://marketgenics.co/download-report-sample/circular-rna-circrna-platforms-market-19161

Expansion of Global Circular RNA platforms Market

"Innovations, strategic planning in circular RNA (circRNA) therapeutics propel the global Circular RNA platforms market expansion"

The global circular RNA platforms market is growing because of ongoing innovations which provide powerful and efficient circRNA technologies that enables advanced applications. For instance, Abogen Biosciences launched the "Cis-System", an innovative RNA circularization cis-splicing platform. This technology enhances circRNA therapeutics by enabling prolonged protein expression, minimizing innate immune responses and allowing flexible splice site design. By improving both stability and functionality, the Cis-System strengthens the commercial potential of circ-RNA based therapies.

Strategic collaborations, innovations between the biotech companies, drug manufacturers and academic centers are taking initiatives in the development of circRNA therapeutics, fueling the growth of circular RNA platforms market. For instance, Porton Advanced Solutions announced a strategic partnership with Guangzhou Geneseed Biotech Co. Ltd. This collaboration leverages Porton's comprehensive gene therapy CDMO (Contract Development and Manufacturing Organization) platform and Geneseed's patented circRNA technologies to drive innovation, accelerate clinical translation, and increase the commercialization of next-generation circRNA therapeutics.

Regional Analysis of Global Circular RNA latforms Market

North America is the leading region for the growth of circular RNA (circRNA) platforms market, driven by dense network of leading research institutions, biotech and pharmaceutical companies and medical centers actively advancing circRNA based therapeutics. The robust infrastructure supports extensive R&D, clinical trials and adoption od circular RNA technologies. For instance, in 2025, Circular Genomics collaborated with Lilly Gateway Labs to advance its circRNA based platforms for enhancing the diagnostic detection and monitoring of Alzheimer's disease biomarkers.

The fastest growth is projected in the circular RNA platforms market of Asia Pacific due to the rapid growth in the scientific facilities, rise in pharmaceutical research and development for investments. Countries such as China, Japan and India are also enhancing their circRNA technologies through establishment of specialized RNA centers, collaborations between biotech firms and academic institutions, expanding global innovation in the circular RNA platforms market. For instance, Researchers from the Indian Institute of Science and Education and Research Bhopal (IISER Bhopal) identified a specific circular RNA (circRNA) called 'ciTRAN'. This circRNA plays a crucial role in the multiplication of the AIDS-causing HIV-1 virus within the human body, potentially leading to new treatment strategies against HIV/AIDS.

Prominent players operating in the global Circular RNA platforms market are Agilent Technologies, Inc., Arraystar Inc., BGI Genomics, CD Genomics, CircCode Therapeutics, Circio, CloudSeq Biotech Inc., Creative Biogene, Geneseed Biotech Co., Ltd., Genscript Biotech Corporation, Illumina, Inc., Laronde (Flagship Pioneering), Lexogen GmbH, Orna Therapeutics, Oxford Nanopore Technologies, PerkinElmer, Inc., QIAGEN N.V., RiboBio Co., Ltd., Ribopion, and Thermo Fisher Scientific Inc. and Other Key Players.

Buy Now: https://marketgenics.co/buy/circular-rna-circrna-platforms-market-19161

The global Circular RNA platforms market has been segmented as follows:

Global Circular RNA platforms Market Analysis, by Type

Exonic ircRNAs

Intronic CircRNAs

Exon-Intron CircRNAs (EIciRNAs)

Intergenic CircRNAs

Mitochondrial CircRNAs

Global Circular RNA platforms Market Analysis, by Technology Platform

Next-Generation Sequencing (NGS) Based Platforms

Microarray-Based Platforms

RT-qPCR Based Platforms

RNA-Seq Based Platforms

Bioinformatics & Computational Platforms

CRISPR-Based CircRNA Tools

Global Circular RNA platforms Market Analysis, by Function/Mechanism

MicroRNA Sponges/Decoys

Protein Scaffolds

Transcription Regulators

Translation Templates

RNA-Binding Protein Regulators

Global Circular RNA platforms Market Analysis, by Workflow Stage

Discovery & Identification

Characterization & Validation

Quantification

Functional Analysis

Therapeutic Development

Global Circular RNA platforms Market Analysis, by Sample Type

Blood/Plasma Samples

Tissue Samples

Cell Line Samples

Exosome-Derived CircRNAs

Saliva Samples

Urine Samples

Others

Global Circular RNA platforms Market Analysis, by Service Type

CircRNA Sequencing Services

CircRNA Library Preparation

Custom CircRNA Synthesis

Bioinformatics Analysis Services

CircRNA Validation Services

Database & Software Solutions

Global Circular RNA platforms Market Analysis, by Disease Area/Application Focus

Oncology/Cancer Research

Cardiovascular Diseases

Neurological Disorders

Metabolic Diseases

Infectious Diseases

Autoimmune Disorders

Rare Genetic Diseases

Others

Global Circular RNA platforms Market Analysis, by End-User Type

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Clinical Diagnostic Laboratories

Contract Research Organizations (CROs)

Hospital & Clinical Research Centers

Government Research Facilities

Global Circular RNA platforms Market Analysis, by Delivery Model

On-Premise Solutions

Cloud-Based Platforms

Hybrid Models

Service-Based/Outsourced Solutions

Global Circular RNA platforms Market Analysis, by Region

North America

Europe

Asia Pacific

Middle East

Africa

South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.

We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.

Contact:

Mr. Debashish Roy

MarketGenics India Pvt. Ltd.

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617

Email: sales@marketgenics.co

Website: https://marketgenics.co

This release was published on openPR.